Sub-Total: $0.00
Family Medicine
Showing 1–16 of 25 results
-
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more -
Advances in Biological Therapy of Crohn’s Disease and Ulcerative Colitis
Read more -
Advances in GLP-1 Receptor Agonists, Insulins and SGLT-2 Inhibitors in the Treatment of Diabetes
Read more -
Biological Therapies for PsA, Osteoarthritis, SLE and Spondyloarthritis: Comparative Effectiveness Based on Treatment Profiles and ACR/EULAR Recommendations
Read more -
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Read more -
Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes
Read more -
Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor
Read more -
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Read more -
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Read more -
Emerging Biological Therapies for Atopic Dermatitis in Children and Adults
Read more -
Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma
Read more -
Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma
Read more -
Emerging Newer Therapies in the Management of Lung Function, Exacerbations, Safety and Tolerability in Patients with COPD
Read more -
Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19
Read more -
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Read more -
Individualized Treatment Options for Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Risk
Read more
